(ARWR) Arrowhead - Performance -32.7% in 12m
ARWR performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-78.55%
#128 in Peer-Group
Rel. Strength
16.25%
#6452 in Stock-Universe
Total Return 12m
-32.73%
#103 in Peer-Group
Total Return 5y
-63.23%
#73 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 111 |
| High / Low | USD |
|---|---|
| 52 Week High | 28.94 USD |
| 52 Week Low | 9.99 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 88.63 |
| Buy/Sell Signal +-5 | 1.61 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ARWR (-32.7%) vs XBI (-11.7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
0.74% | 53.2% | 70.2% | 24.1 | 14.3 | 0.24 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
3.64% | -10.3% | 158% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.83% | -8.28% | 33.6% | 27.4 | 14.2 | 0.99 | 0.60% | 41% |
| NBIX NASDAQ Neurocrine Biosciences |
7.39% | -7.29% | 0.13% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| BIM PA Biomerieux |
-1% | 26.9% | -7.57% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
4.06% | 31.3% | -17.2% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.56% | 41.9% | -8.93% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
- | 27% | 13.6% | 28.8 | 15.2 | 0.63 | -62.1% | -19.3% |
Performance Comparison: ARWR vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ARWR
| Total Return (including Dividends) | ARWR | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 21.61% | 7.34% | 5.42% |
| 3 Months | 67.70% | 16.06% | 19.66% |
| 12 Months | -32.73% | -11.67% | 14.17% |
| 5 Years | -63.23% | -26.49% | 107.98% |
| Trend Stabilty (consistency of price movement) | ARWR | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 92.2% | 88.2% | 91.9% |
| 3 Months | 86.9% | 79.7% | 97.6% |
| 12 Months | -80.5% | -86.7% | 47.9% |
| 5 Years | -91.3% | -51.5% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th77.00 | 13.30% | 15.36% |
| 3 Month | %th83.50 | 44.49% | 40.15% |
| 12 Month | %th49.00 | -23.83% | -41.08% |
| 5 Years | %th64.50 | -49.98% | -82.32% |
FAQs
Does Arrowhead (ARWR) outperform the market?
No,
over the last 12 months ARWR made -32.73%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.67%.
Over the last 3 months ARWR made 67.70%, while XBI made 16.06%.
Performance Comparison ARWR vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ARWR vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -0.4% | 16.2% | -9.4% | -47% |
| US NASDAQ 100 | QQQ | -1.2% | 15.3% | -11.6% | -50% |
| German DAX 40 | DAX | 0.3% | 17.6% | -19.7% | -64% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -0.9% | 15.5% | -13.1% | -52% |
| Hongkong Hang Seng | HSI | -1.7% | 17.1% | -29.8% | -68% |
| India NIFTY 50 | INDA | 0.4% | 19.4% | -11.1% | -30% |
| Brasil Bovespa | EWZ | 0.1% | 23.1% | -23.4% | -34% |
ARWR vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -0% | 18.2% | -13.8% | -59% |
| Consumer Discretionary | XLY | 0.5% | 16.7% | -0.2% | -49% |
| Consumer Staples | XLP | -0.1% | 20.2% | -9.9% | -38% |
| Energy | XLE | 2.3% | 23.1% | 2.7% | -29% |
| Financial | XLF | 0.3% | 16.7% | -8.9% | -54% |
| Health Care | XLV | 2.6% | 21.7% | 0.9% | -22% |
| Industrial | XLI | -0.8% | 14.8% | -14.5% | -54% |
| Materials | XLB | 2.4% | 17.9% | -6.5% | -33% |
| Real Estate | XLRE | -0.3% | 20.8% | -6.8% | -38% |
| Technology | XLK | -1.6% | 13.3% | -15.5% | -50% |
| Utilities | XLU | 0.2% | 18.4% | -9.6% | -54% |
| Aerospace & Defense | XAR | -6.4% | 8.8% | -33% | -85% |
| Biotech | XBI | 0.2% | 14.3% | -3.8% | -21% |
| Homebuilder | XHB | 3.4% | 11.5% | 3.4% | -25% |
| Retail | XRT | 1.8% | 17.1% | -5.5% | -36% |
ARWR vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -1.1% | 29.1% | 4.08% | -27% |
| Natural Gas | UNG | -6.5% | 32.3% | 10.8% | -47% |
| Gold | GLD | -0.5% | 23% | -27% | -68% |
| Silver | SLV | -2.7% | 18.9% | -29.1% | -58% |
| Copper | CPER | 1.8% | 7.6% | -29% | -57% |
ARWR vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 2.1% | 22.9% | -3.4% | -27% |
| iShares High Yield Corp. Bond | HYG | -0.1% | 20.2% | -7.4% | -41% |